Ingevity Corporation
NGVT
$71.64
-$0.39-0.54%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.71% | -10.14% | -17.19% | -30.23% | -29.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.71% | -10.14% | -17.19% | -30.23% | -29.08% |
| Cost of Revenue | -3.14% | -19.48% | -28.62% | -44.07% | -39.27% |
| Gross Profit | -2.04% | 8.04% | 8.15% | 5.16% | -4.19% |
| SG&A Expenses | 8.56% | 2.82% | -2.24% | -15.88% | -14.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.60% | -15.34% | -24.25% | -39.80% | -35.66% |
| Operating Income | -9.35% | 11.26% | 15.95% | 23.46% | 4.71% |
| Income Before Tax | -1.07% | 96.05% | 93.89% | 71.39% | -1,291.09% |
| Income Tax Expenses | 143.46% | 164.64% | 140.40% | 109.12% | -306.38% |
| Earnings from Continuing Operations | -23.81% | 79.87% | 83.86% | 59.95% | -2,148.15% |
| Earnings from Discontinued Operations | 98.03% | 99.81% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.17% | 88.31% | 49.78% | -215.61% | -7,868.52% |
| EBIT | -9.35% | 11.26% | 15.95% | 23.46% | 4.71% |
| EBITDA | -9.11% | 3.11% | 5.09% | 10.31% | -0.38% |
| EPS Basic | 60.91% | 88.40% | 49.96% | -214.30% | -6,109.59% |
| Normalized Basic EPS | -51.43% | 110.09% | 120.17% | 201.44% | 89.30% |
| EPS Diluted | 60.64% | 88.23% | 50.09% | -212.31% | -5,222.66% |
| Normalized Diluted EPS | -51.72% | 109.75% | 120.36% | 202.59% | 90.39% |
| Average Basic Shares Outstanding | -0.29% | 0.23% | 0.33% | 0.20% | -0.50% |
| Average Diluted Shares Outstanding | 0.25% | 0.76% | 0.52% | 0.23% | -0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |